DZ3164A1 - Nouvel agent pharmaceutique. - Google Patents

Nouvel agent pharmaceutique.

Info

Publication number
DZ3164A1
DZ3164A1 DZ003164A DZ003164A DZ3164A1 DZ 3164 A1 DZ3164 A1 DZ 3164A1 DZ 003164 A DZ003164 A DZ 003164A DZ 003164 A DZ003164 A DZ 003164A DZ 3164 A1 DZ3164 A1 DZ 3164A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical agent
new pharmaceutical
new
agent
pharmaceutical
Prior art date
Application number
DZ003164A
Other languages
English (en)
French (fr)
Inventor
Paul David James Blackler
Robert Gordon Giles
Stephen Moore
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909471.6A external-priority patent/GB9909471D0/en
Priority claimed from GBGB9912195.6A external-priority patent/GB9912195D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ3164A1 publication Critical patent/DZ3164A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DZ003164A 1999-04-23 2000-04-19 Nouvel agent pharmaceutique. DZ3164A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909471.6A GB9909471D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912195.6A GB9912195D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical
PCT/GB2000/001522 WO2000064893A2 (en) 1999-04-23 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
DZ3164A1 true DZ3164A1 (fr) 2000-11-02

Family

ID=26315459

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ003164A DZ3164A1 (fr) 1999-04-23 2000-04-19 Nouvel agent pharmaceutique.

Country Status (36)

Country Link
EP (2) EP1277753A1 (bg)
JP (1) JP2002543076A (bg)
KR (1) KR100744361B1 (bg)
CN (1) CN1152878C (bg)
AP (1) AP1607A (bg)
AR (2) AR023560A1 (bg)
AU (2) AU4307200A (bg)
BG (1) BG65517B1 (bg)
BR (1) BR0009935A (bg)
CA (1) CA2370262A1 (bg)
CO (1) CO5170419A1 (bg)
CZ (1) CZ20013801A3 (bg)
DZ (1) DZ3164A1 (bg)
EA (1) EA003031B1 (bg)
EG (1) EG23937A (bg)
GC (1) GC0000250A (bg)
HK (1) HK1045152A1 (bg)
HR (1) HRP20010774A2 (bg)
HU (1) HUP0200937A3 (bg)
IL (1) IL146115A0 (bg)
MA (1) MA26786A1 (bg)
MX (1) MXPA01010822A (bg)
MY (1) MY138673A (bg)
NO (1) NO320587B1 (bg)
NZ (1) NZ515167A (bg)
OA (1) OA11873A (bg)
PE (1) PE20010045A1 (bg)
PL (1) PL351685A1 (bg)
SK (1) SK14932001A3 (bg)
TR (1) TR200103060T2 (bg)
TW (1) TWI288749B (bg)
UA (1) UA67845C2 (bg)
UY (1) UY26119A1 (bg)
WO (1) WO2000064893A2 (bg)
YU (1) YU75401A (bg)
ZA (1) ZA200108718B (bg)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
JP2002541785A (ja) * 1999-04-13 2002-12-10 アメリカ合衆国 クローン化ヌクレオチド配列からの弱毒化キメラ呼吸系発疹ウイルスワクチンの製造
ATE247653T1 (de) 1999-04-23 2003-09-15 Smithkline Beecham Plc Thiazolidindionderivat und seine verwendung als antidiabetikum
ATE246191T1 (de) 1999-04-23 2003-08-15 Smithkline Beecham Plc Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) * 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
WO2004062667A1 (en) * 2003-01-08 2004-07-29 Dr. Reddy's Laboratories Limited Amorphous form of rosiglitazone maleate and process for preparation thereof
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
TW200838512A (en) * 2007-02-08 2008-10-01 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10199003I1 (de) * 1987-09-04 2003-06-12 Beecham Group Plc Substituierte Thiazolidinionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
NZ515167A (en) 2004-02-27
IL146115A0 (en) 2002-07-25
UY26119A1 (es) 2000-12-29
BG106122A (bg) 2002-05-31
MA26786A1 (fr) 2004-12-20
CA2370262A1 (en) 2000-11-02
NO320587B1 (no) 2005-12-27
EG23937A (en) 2008-01-14
YU75401A (sh) 2004-09-03
PL351685A1 (en) 2003-06-02
HK1045152A1 (zh) 2002-11-15
EP1175418A2 (en) 2002-01-30
AR023560A1 (es) 2002-09-04
HUP0200937A3 (en) 2004-03-29
AU2755102A (en) 2002-05-16
AR023750A1 (es) 2002-09-04
EP1277753A1 (en) 2003-01-22
MY138673A (en) 2009-07-31
KR20010110804A (ko) 2001-12-13
KR100744361B1 (ko) 2007-07-30
GC0000250A (en) 2006-11-01
HRP20010774A2 (en) 2002-10-31
TWI288749B (en) 2007-10-21
EA200101122A1 (ru) 2002-04-25
CN1355800A (zh) 2002-06-26
TR200103060T2 (tr) 2002-05-21
OA11873A (en) 2006-03-27
AP2001002329A0 (en) 2001-12-31
NO20015148L (no) 2001-12-17
MXPA01010822A (es) 2002-06-04
BR0009935A (pt) 2002-04-16
NO20015148D0 (no) 2001-10-22
JP2002543076A (ja) 2002-12-17
ZA200108718B (en) 2002-12-03
AP1607A (en) 2006-05-03
AU771342B2 (en) 2004-03-18
BG65517B1 (bg) 2008-10-31
CN1152878C (zh) 2004-06-09
SK14932001A3 (sk) 2002-02-05
WO2000064893A3 (en) 2001-01-25
PE20010045A1 (es) 2001-03-10
AU4307200A (en) 2000-11-10
WO2000064893A2 (en) 2000-11-02
HUP0200937A2 (en) 2002-08-28
UA67845C2 (uk) 2004-07-15
EA003031B1 (ru) 2002-12-26
CZ20013801A3 (cs) 2002-07-17
CO5170419A1 (es) 2002-06-27

Similar Documents

Publication Publication Date Title
TR199901077A3 (tr) Ispençiyari formülasyonlar.
MA26937A1 (fr) Nouvelle composition pharmaceutique.
FI991485A (fi) Uusi farmaseuttinen koostumus
NL1015859A1 (nl) Farmaceutische preparaten.
NO20015175L (no) Farmasöytisk sammensetning
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
ITTO20010005A1 (it) Formulazione farmaceutica.
BR0014930B1 (pt) cÂnula.
DE60016271D1 (de) Medikamentenzuführvorrichtung
DE122010000009I2 (de) Beta2-adrenoceptor agonisten.
BR0013705B1 (pt) sistema cirérgico.
NO20020304D0 (no) Konserverte farmasöytiske preparater
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
MXPA03001425A (es) Compuestos farmaceuticos.
DK1275397T3 (da) Lægemiddel til lokal anvendelse
NO20022606L (no) Farmasöytiske kombinasjoner
DZ3164A1 (fr) Nouvel agent pharmaceutique.
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
NO20014926D0 (no) Farmasöytiske forbindelser
DK1227817T3 (da) Ciclesonid-holdigt vandigt farmaceutisk præparat
FI4488U1 (fi) Farmaseuttinen koostumus
DZ3162A1 (fr) Nouveau composé pharmaceutique.
MA26801A1 (fr) Complexe pharmaceutique
DZ3163A1 (fr) Nouvelle substance pharmaceutique.
AR025867A1 (es) Formulacion portasdora farmaceutica